Andrew Whitehead: 13 Years of Unnecessary Chemotherapy at Coventry NHS Trust
Andrew Whitehead spent 13 years on chemotherapy for a tumor later found to be low-grade. His case is among over 40 investigated at Coventry NHS Trust.
Andrew Whitehead: 13 Years of Unnecessary Chemotherapy at Coventry NHS Trust Andrew Whitehead spent 13 years on chemotherapy for a tumor later found to be low-grade. His case is among over 40 investigated at Coventry NHS Trust. Andrew Whitehead, a 45-year-old man from Coventry, endured 13 years of chemotherapy after being diagnosed in 2010 with an aggressive, life-limiting tumor that later turned out to be low-grade and may never have required such treatment. Whitehead was 29 when he had surgery to remove a tumor from his neck at a hospital in Coventry in 2010. He was subsequently told he had a high-grade aggressive tumor and that chemotherapy and radiotherapy were his only options.Now 45, Whitehead says he was effectively told to prepare to die and spent more than a decade organizing his life around repeated cycles of chemotherapy. The treatment only stopped after a new oncologist took over his care in 2024 and his case was reviewed.Independent medical evidence obtained by his lawyers has since indicated that his tumor was a much lower grade and that he should not have received chemotherapy at all, according to law firm Brabners.Investigation into Coventry NHS TrustHis case is among more than 40 being investigated by lawyers over claims of prolonged or allegedly unnecessary chemotherapy treatment at University Hospitals Coventry and Warwickshire NHS Trust, with all patients under the care of Dr Ian Brown.The investigation comes as an interim review by the Royal College of Physicians has found serious failings in the care of patients who were prescribed prolonged courses of the chemotherapy drug temozolomide at the Coventry trust.The RCP examined 20 cases and found 15 were unsatisfactory overall, with none judged to represent good practice. Its preliminary findings said patients had been prescribed extended courses with little or no evidence of benefit and described the failings as a betrayal of patient trust. The full review is expected to be published later this autumn.Whitehead's Decade of TreatmentReflecting on the revelation, Whitehead told the Daily Mail that he believed he did not have long and was going to die. He hoped the treatment would extend his life, but he did not honestly know how long that would be. It was just a case of taking one day at a time and seeing what happens, he said.The treatment became his life, really. Taking the chemotherapy as he was told was his one and only focus, because that was the thing he hoped would keep him alive. Whitehead was given 30 sessions of radiotherapy and chemotherapy at the beginning of his treatment. For most of the next 13 years, he took chemotherapy tablets for five days, followed by three weeks off, before starting another cycle.You do not just recover straight away. You have to slowly come out of it and, by the time you start to feel okay, it is time for the next cycle again. Eventually, the routine became so entrenched that he could scarcely remember life before it. After a few years it just became normal. It sounds stupid, but it just became my life. I did not know anything else. My old life had disappeared and this was the new life that I had to lead to stay alive.There was a constant monotony of taking the tablets, going for a scan, hoping the scan was fine, which it usually was, and then you breathe a little bit and think, okay, I have got another six months now; I need to do the best I can to get to the next scan. That was how I lived my life, from scan to scan.Then came the news that turned his world upside down. He was told that the tumor was actually low-grade and that his original diagnosis had been wrong. I was shocked and I was relieved, because being told you have a low-level cancer is not as stressful. I was told I was coming off my tablets, and that was causing me a lot of stress because I had been told the tablets were keeping me alive.A Freedom of Information request showed that between 2007 and 2023 Coventry had spent 3.6 million pounds on temozolomide, around ten times more than any other neuro-oncology center they examined.Impact on Whitehead's LifeIt was not until he drove home that the enormity of what he had been told began to sink in. Since finding out what I have found out, every time I look back I feel anger and sadness. All those years were taken away from me.Whitehead says he had been forced to abandon almost every part of his former life. He left a job he had worked at for around four-and-a-half years, gave up weight training, saw friends less often, and stopped going out. I had to stop everything just to concentrate on taking the tablets and trying to keep myself alive.
Original source:
Head Topics
Comments 0